drugset / Trial / NCT00282828
Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
Phase 4
Completed
397 enrolled
Massachusetts General Hospital
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline.
Timeline
- Start
- 2006-03
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonazepam | Small molecule | — | — |
| Subject | Venlafaxine | Small molecule | — | — |
| Background | Sertraline | Small molecule | — | — |